| MeSH term | MeSH ID | Detail |
|---|---|---|
| Chemical and Drug Induced Liver Injury | D056486 | 39 associated lipids |
| Lymphoma, Primary Effusion | D054685 | 2 associated lipids |
| Cholangiocarcinoma | D018281 | 7 associated lipids |
| Lymphoma, Large B-Cell, Diffuse | D016403 | 13 associated lipids |
| HIV Infections | D015658 | 20 associated lipids |
| Colorectal Neoplasms | D015179 | 10 associated lipids |
| Tangier Disease | D013631 | 8 associated lipids |
| Osteosarcoma | D012516 | 50 associated lipids |
| Neuroblastoma | D009447 | 66 associated lipids |
| Mycoses | D009181 | 18 associated lipids |
| Lung Neoplasms | D008175 | 171 associated lipids |
| Hyperlipoproteinemias | D006951 | 15 associated lipids |
| Carcinoma, Hepatocellular | D006528 | 140 associated lipids |
| Hemolysis | D006461 | 131 associated lipids |
| Carcinoma, Non-Small-Cell Lung | D002289 | 72 associated lipids |
| Carcinoma | D002277 | 18 associated lipids |
| Body Weight | D001835 | 333 associated lipids |
| Blastomycosis | D001759 | 5 associated lipids |
| Arteriosclerosis | D001161 | 86 associated lipids |
| Anemia, Hemolytic, Congenital | D000745 | 5 associated lipids |
18194-24-6
18194-24-6 is a lipid of Glycerophospholipids (GP) class. 18194-24-6 is associated with abnormalities such as Cerebrovascular accident, Renal tubular disorder, Atherosclerosis, Hyperlipoproteinemia Type III and Lipid Metabolism Disorders. The involved functions are known as Process, protein folding, Catalyst, Biochemical Pathway and Fold in Medical Device Material. 18194-24-6 often locates in Tissue membrane, Membrane, periplasm, vesicle membrane and outer membrane. The associated genes with 18194-24-6 are Integral Membrane Proteins, Protein Structure, RTN4 gene, RTN4R gene and Protein, Organized by Structure. The related lipids are Micelles, dimyristoylphosphatidylglycerol, 1,2-dihexadecyl-sn-glycero-3-phosphocholine, Unilamellar Vesicles and cholesteryl oleate. The related experimental models are Mouse Model, Arthritis, Adjuvant-Induced, Disease model and Xenograft Model.
Cross Reference
Introduction
To understand associated biological information of 18194-24-6, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with 18194-24-6?
18194-24-6 is suspected in Atherosclerosis, Cardiovascular Diseases, Dehydration, Abnormal shape, Renal tubular disorder, Hyperlipoproteinemia Type III and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with 18194-24-6
PubChem Associated disorders and diseases
What pathways are associated with 18194-24-6
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with 18194-24-6?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with 18194-24-6?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with 18194-24-6?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with 18194-24-6?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with 18194-24-6?
Mouse Model
Mouse Model are used in the study 'Association of a model class A (apolipoprotein) amphipathic alpha helical peptide with lipid: high resolution NMR studies of peptide.lipid discoidal complexes.' (Mishra VK et al., 2006).
Arthritis, Adjuvant-Induced
Arthritis, Adjuvant-Induced are used in the study 'T cell antigen receptor peptide-lipid membrane interactions using surface plasmon resonance.' (Bender V et al., 2004).
Disease model
Disease model are used in the study 'Kupffer cells do not play a role in governing the efficacy of liposomal mitoxantrone used to treat a tumor model designed to assess drug delivery to liver.' (Lim HJ et al., 2000).
Related references are published most in these journals:
| Model | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
NCBI Entrez Crosslinks
All references with 18194-24-6
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Blaser G et al. | Free-energy relationships for the interactions of tryptophan with phosphocholines. | 2009 | Org. Biomol. Chem. | pmid:20024107 |
| Gagnon MC et al. | Evaluation of the effect of fluorination on the property of monofluorinated dimyristoylphosphatidylcholines. | 2014 | Org. Biomol. Chem. | pmid:24899513 |
| Guimond-Tremblay J et al. | Synthesis and properties of monofluorinated dimyristoylphosphatidylcholine derivatives: potential fluorinated probes for the study of membrane topology. | 2012 | Org. Biomol. Chem. | pmid:22179779 |
| Houdai T et al. | Structure of membrane-bound amphidinol 3 in isotropic small bicelles. | 2008 | Org. Lett. | pmid:18767855 |
| Yoshizawa J et al. | Inhibitory effect of drug-free hybrid liposomes on metastasis of human neuroblastoma. | 2011 | Pediatr. Surg. Int. | pmid:21327948 |
| Zhong Q et al. | Secondary structures of lipid-associating peptides: a Fourier transform infrared study. | 1994 Mar-Apr | Pept. Res. | pmid:7516748 |
| Creuzenet C et al. | Interaction of alpha s2- and beta-casein signal peptides with DMPC and DMPG liposomes. | 1997 | Peptides | pmid:9210162 |
| Barbosa RM et al. | Influence of different surfactants on the physicochemical properties of elastic liposomes. | 2017 | Pharm Dev Technol | pmid:27050395 |
| Cagdas FM et al. | Effect of preparation method and cholesterol on drug encapsulation studies by phospholipid liposomes. | 2011 | Pharm Dev Technol | pmid:20433249 |
| Katz M et al. | Rapid colorimetric screening of drug interaction and penetration through lipid barriers. | 2006 | Pharm. Res. | pmid:16511676 |
| Jin B and Hopfinger AJ | Characterization of lipid membrane dynamics by simulation: 3. Probing molecular transport across the phospholipid bilayer. | 1996 | Pharm. Res. | pmid:8987072 |
| Bethune C et al. | Lipid association increases the potency against primary medulloblastoma cells and systemic exposure of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) in rats. | 1999 | Pharm. Res. | pmid:10397611 |
| Vrhovnik K et al. | Influence of liposome bilayer fluidity on the transport of encapsulated substance into the skin as evaluated by EPR. | 1998 | Pharm. Res. | pmid:9587946 |
| Austin RP et al. | The thermodynamics of the partitioning of ionizing molecules between aqueous buffers and phospholipid membranes. | 2005 | Pharm. Res. | pmid:16180122 |
| Lance MR et al. | Evidence for the formation of amphotericin B-phospholipid complexes in Langmuir monolayers. | 1996 | Pharm. Res. | pmid:8842037 |
| Saunders M et al. | High sensitivity differential scanning calorimetry study of DNA-cationic liposome complexes. | 2007 | Pharm. Res. | pmid:17551810 |
| Rogers JA et al. | Solubilization of liposomes by weak electrolyte drugs. I. Propranolol. | 1990 | Pharm. Res. | pmid:2235897 |
| Bourré L et al. | In vivo photosensitizing efficiency of a diphenylchlorin sensitizer: interest of a DMPC liposome formulation. | 2003 | Pharmacol. Res. | pmid:12591021 |
| Debouzy JC et al. | Hexakis (3,6-anhydro)-tetrakis[2(I,II,IV,V)-O-(2-ethoxyethyl)] derivatives of (3,6-anhydro)-alpha-cyclodextrin exhibits novel cation affinities and tensioactive properties on membranes. | 2007 | Pharmazie | pmid:18214338 |
| Essex JW et al. | Molecular dynamics simulation of a hydrated phospholipid bilayer. | 1994 | Philos. Trans. R. Soc. Lond., B, Biol. Sci. | pmid:7938199 |